// News

In The Know: Healthcare News for February 10, 2020

Tags: Abbott, Aria CV, Beta.mn, Bob Sheehy, Bright Health, collider, Coloplast, Destination Medical Center, DMC, Geoff Martha, Healthy.io, Heraeus Medical, Imricor, Mayo Clinic, Medtronic, Minnetronix Medical, Nuvaira, Pops! Diabetes Care, Rebiotix, Starkey Hearing Technologies, Surmodics, University of Minnesota

Aria CV Receives FDA Breakthrough Designation for Its Medical Device for Treating Pulmonary Arterial Hypertension

Abbott’s In-Development Fully Implantable Heart Pump System Earns FDA’S Breakthrough Device Designation

Mayo Clinic again receives top honors for high-quality patient care

Nuvaira Announces Chief Financial Officer and Pivotal Study Milestone

Rebiotix, a Ferring Company, Completes Enrollment for First-Ever, Pivotal Phase 3 Clinical Trial of Microbiota-based RBX2660

Geoff Martha, Bob Sheehy named to national list of execs to watch

UMN researchers make advances in drug addiction treatment

DMCC Board Doubles Down on Discovery Square in Rochester, Minnesota

St. Paul-based Minnetronix gets $1 million in state grants and loans

Collider Offering ‘Microgrants’ for Rochester Startups

The top 10 medical device states: Everything you need to know

Coloplast Delivers Solid Start to the Year with 8% Organic Growth

Australian winner of Zurich’s global Innovation Championship announced

Heraeus Medical Components acquires Contract Medical International

Starkey Appoints Dr. Archelle Georgiou as the Industry’s First and Only Chief Health Officer

Israeli med-tech start-up launches smartphone app to monitor wounds

Surmodics Names Nusrath Sultana, MD, as Vice President, Clinical Affairs

Imricor Medical Systems (ASX:IMR) completes heart surgery on patients in Germany

New Beta.MN leader seeks a bigger tent for Minnesota startups